Puspa R. Pandey

National Cancer Institute — United States

Medicine · Health Sciences

15h-index2.0kcitations55works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(11), Cancer, Hypoxia, and Metabolism(10), Cancer-related molecular mechanisms research(9), Cancer, Lipids, and Metabolism(7), Mechanisms of cancer metastasis(7)

Publications55 total

Role of Myc family proteins in transcriptional regulation of growth and oncogenic transformation in fusion-positive rhabdomyosarcoma
2025Open Access
Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma
Molecular Cancer Therapeutics·2025· 1 citedOpen Access
Abstract 3536: Role of Myc family proteins in fusion-positive rhabdomyosarcoma
Cancer Research·2023
Supplementary Table 1 from A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
2023Open Access
Supplementary Legends from A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
2023Open Access
Data from A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
2023Open Access
Supplementary Figures from A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
2023Open Access
Supplementary Figures from A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
2023Open Access
Supplementary Legends from A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
2023Open Access
Data from A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
2023Open Access
Supplementary Table 1 from A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
2023Open Access
Data from Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem–Like Cells with Macrophages and Stromal Cells
2023Open Access
Supplementary Methods, Figures 1-7, Tables 1-7 from Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem–Like Cells with Macrophages and Stromal Cells
2023Open Access
Data from Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem–Like Cells with Macrophages and Stromal Cells
2023Open Access
Supplementary Methods, Figures 1-7, Tables 1-7 from Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem–Like Cells with Macrophages and Stromal Cells
2023Open Access
LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c
Breast Cancer Research·2022· 11 citedOpen Access
Prevalence of Staphylococci in Environmental Surfaces and Characterization of Isolates by Antibiotic Susceptibility
Tribhuvan University Journal of Microbiology·2021· 1 citedOpen Access
A Fusion Transcription Factor–Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target
Cancer Research·2021· 27 citedOpen Access
Expansion of Human Pluripotent Stem Cells in Stirred Tank Bioreactors
Methods in molecular biology·2021· 1 cited
Abstract 3888: Study of tumor recurrence following loss of PAX3-FOXO1 oncoprotein expression in rhabdomyosarcoma cells
Cancer Research·2020
page 1 of 3Next →

Frequent Co-authors

Fei Xing(30), Kounosuke Watabe(30), Aya Kobayashi(26), Misako Watabe(26), Sudha K. Pai(26), Hiroshi Okuda(20), Shigeru Hirota(17), Koji Fukuda(16), Bishwanath Chatterjee(12), Frederic G. Barr(12), Andrew Wilber(11), Salah Boudjadi(10), Wenyue Sun(10), Sambad Sharma(8), Yin‐Yuan Mo(8), Wen Liu(8), Kerui Wu(7), Vishnu Modur(7), Hiroshi Okuda(6), Megumi Iiizumi(5)